Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$247,364,170
-$622,205 QoQ
Shares Held
1,925,013
-6.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#116
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. MRK ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,364,170 | 1,925,013 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $247,986,375 | 2,061,571 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $222,324,066 | 2,112,142 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $193,929,916 | 2,310,615 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $274,073,214 | 3,462,269 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $282,809,883 | 3,150,734 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $445,012,339 | 4,473,385 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $231,884,409 | 2,041,955 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $252,709,721 | 2,041,274 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $269,370,383 | 2,041,458 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $222,381,721 | 2,039,825 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $210,047,237 | 2,040,284 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $235,296,710 | 2,039,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $216,902,825 | 2,038,752 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $226,104,339 | 2,037,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $175,419,292 | 2,036,917 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,700,526 | 2,036,860 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $167,133,880 | 2,036,976 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $156,034,978 | 2,035,947 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $173,616,389 | 2,311,495 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $179,668,842 | 2,310,259 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $412,694,522 | 5,353,409 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $457,281,835 | 5,590,245 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $463,503,579 | 5,587,744 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $432,186,190 | 5,588,853 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $429,486,826 | 5,582,103 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||